More Articles

Obama’s fresh attempts to ease drugs shortages in the US Pharma News | Posted 04/11/2011

Action by the PresidentPresident Barack Obama signed an executive order 31 October 2011 to address an escalating shortage of life-saving medicines, his newest effort to advance social and economic...

Translational research to uncover new uses for generics Generics/Research | Posted 04/11/2011

On the surface, generic compounds and translational medicines could not appear more different. However, in April 2011, the US National Institutes of Health (NIH) met with academic, governmental, an...

Can biosimilar manufacturers learn from generic substitution issues Biosimilars/Research | Posted 04/11/2011

The substitution of generic prescription medicines for branded medicines is practiced in most Westernised countries, mainly because of its clear economic benefits. Patient experiences of generic su...

Pay-to-delay debate hits South Africa Reports | Posted 04/11/2011

A report issued in August 2011 by the US Federal Trade Commission (FTC), on the short and long-term effects of authorised generics has sparked a debate over how this affects generics in South Africa.

Generic olanzapine now approved in US Generics/News | Posted 04/11/2011

Eli Lilly has no safe haven left as the FDA announced on 24 October 2011 that it had approved the first generic olanzapine (for treating schizophrenia and bipolar disorder) drugs, one day after the...

US biosimilars: a report on FDA progress Biosimilars/Research | Posted 04/11/2011

This article reviews the steps being taken by FDA to implement the Biologics Price Competition and Innovation (BPCI) Act of 2009, enshrined in law in 2010 as the ‘biosimilars statute’.

Overprescribing of drugs ‘chronic’ in Europe Reports | Posted 04/11/2011

Salzburg Medical University, Austria, is the latest body to report the ‘chronic’ overprescribing of drugs for the elderly in Europe. The study found that 36% of prescriptions given to patients with...

South Africa-India alliances for generics and drug delivery systems Generics/News | Posted 04/11/2011

South Africa-based Litha Healthcare Group signed an exclusive agreement with Indian generic drugmaker Natco Pharma (Natco) on 19 September 2011. Under the group’s newly formed generics business uni...